GlaxoSmithKline (GLAXO) is ready for a bullish rally

GlaxoSmithKline (GLAXO) is currently consolidating after a long bullish rally. Key resistance lies at 445-446. A break above this level will lead to further rally. Key support lies at 360.

With the earnings of the pharmaceutical sector on the rise due to deregulation of prices, a good result from GLAXO is also expected. The stock has also become part of many mutual funds’ holding. A share to keep an eye on.

⚠️ This post reflects the author’s personal opinion and is for informational purposes only. It does not constitute financial advice. Investing involves risk and should be done independently. Read full disclaimer →

📢 Announcement: We're on WhatsApp – Join Us There! 

Here's what you get:

• Member-Only Discussion Community
• Research Reports with Explanations & Expert Views
• Access to Exclusive KSEStocks Market Reports
• Model Portfolio with Clear Investment Rationale
• Monthly Portfolio Review & Health Check
• On-Demand Stock Coverage Requests
• PSX Facilitation (CDC Account, Share Transfer, Physical Conversion)